We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$455M
1-Year Est. Return
218.66%
This Fund
S&P 500
This Quarter
Est. Return
+71.21%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$491M
AUM Growth
+$188M
(+62%)
Cap. Flow
+$45.5M
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
18.99%
Holding
156
New
44
Increased
44
Reduced
29
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$7.26M |
| 2 |
Ollie's Bargain Outlet
OLLI
|
+$6.35M |
| 3 |
CareDx
CDNA
|
+$6.35M |
| 4 |
Cloudflare
NET
|
+$5.7M |
| 5 |
Lattice Semiconductor
LSCC
|
+$5.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIVE9
FIVN
|
+$9.22M |
| 2 |
FTI Consulting
FCN
|
+$6.26M |
| 3 |
Itron
ITRI
|
+$6.25M |
| 4 |
Repligen
RGEN
|
+$6.07M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$5.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.1% |
| 2 | Technology | 22.24% |
| 3 | Industrials | 19.83% |
| 4 | Consumer Discretionary | 16.89% |
| 5 | Financials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
eHealth
EHTH
$27.5M
| – | – |
-37,115
| Closed | -$5.23M |
|
127
Fate Therapeutics
FATE
$292M
| – | – |
-14,780
| Closed | -$328K |
|
|
128
FTI Consulting
FCN
$4.01B
| – | – |
-52,308
| Closed | -$6.26M |
|
129
Fabrinet
FN
$14B
| – | – |
-49,047
| Closed | -$2.68M |
|
130
Grocery Outlet
GO
$1.13B
| – | – |
-49,030
| Closed | -$1.68M |
|
131
Goosehead Insurance
GSHD
$1.35B
| – | – |
-32,250
| Closed | -$1.44M |
|
|
GTLS
132
DELISTED
Chart Industries
GTLS
| – | – |
-54,865
| Closed | -$1.59M |
|
133
HEICO Corp
HEI
$41.7B
| – | – |
-7,585
| Closed | -$566K |
|
|
134
Itron
ITRI
$4.03B
| – | – |
-111,888
| Closed | -$6.25M |
|
135
Lumentum
LITE
$82.2B
| – | – |
-48,903
| Closed | -$3.6M |
|
136
MongoDB
MDB
$30.2B
| – | – |
-13,525
| Closed | -$1.85M |
|
137
NeoGenomics
NEO
$2.42B
| – | – |
-152,391
| Closed | -$4.21M |
|
138
Omnicell
OMCL
$1.48B
| – | – |
-36,090
| Closed | -$2.37M |
|
139
Paylocity
PCTY
$7.81B
| – | – |
-33,623
| Closed | -$2.97M |
|
140
Planet Fitness
PLNT
$3.75B
| – | – |
-92,616
| Closed | -$4.51M |
|
141
Insulet
PODD
$9.77B
| – | – |
-11,212
| Closed | -$1.86M |
|
142
Papa John's
PZZA
$663M
| – | – |
-62,778
| Closed | -$3.35M |
|
143
Rocket Pharmaceuticals
RCKT
$380M
| – | – |
-38,910
| Closed | -$543K |
|
144
RingCentral
RNG
$6.14B
| – | – |
-14,463
| Closed | -$3.06M |
|
145
Teladoc Health
TDOC
$1.17B
| – | – |
-22,595
| Closed | -$3.5M |
|
|
UCTT
146
Ultra Clean Holdings
UCTT
$2.99B
| – | – |
-140,140
| Closed | -$1.93M |
|
147
WEX
WEX
$6.73B
| – | – |
-25,435
| Closed | -$2.66M |
|
148
Zoom
ZM
$26.9B
| – | – |
-8,820
| Closed | -$1.29M |
|
|
EVBG
149
DELISTED
Everbridge, Inc. Common Stock
EVBG
| – | – |
-27,426
| Closed | -$2.92M |
|
|
SWAV
150
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-32,340
| Closed | -$1.07M |
|
Similar funds
HFA
BI
PIM
GA
MI
MC
CFO
IIA
Lisanti Capital Growth's Q2 2020 Portfolio in Review
As of Q2 2020, Lisanti Capital Growth held 156 positions worth $491M, up 62% from $303M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Lisanti Capital Growth deployed $45.5M of net new capital in Q2 2020, opening 44 new positions and adding to 44 existing holdings. Its largest new stake was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was FIVE9, an estimated $9.22M trimmed.
- Lisanti Capital Growth's largest Q2 2020 buy was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
- Lisanti Capital Growth added most to Patrick Industries in Q2 2020, an estimated $4.65M increase.
- Lisanti Capital Growth's biggest Q2 2020 reduction was FIVE9, cutting an estimated $9.22M.
- Lisanti Capital Growth fully exited FTI Consulting in Q2 2020, selling an estimated $6.26M.
- Lisanti Capital Growth's ten largest holdings make up 19% of its $491M portfolio in Q2 2020.
- Lisanti Capital Growth opened 44 new positions and closed 39 in Q2 2020.
- Lisanti Capital Growth's portfolio value rose 62% quarter-over-quarter to $491M.
Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.